EKF develops point-of-care in-vitro diagnostic devices and tests, providing quick, accurate results for healthcare professionals to make rapid decisions at or near the patient’s location.
EKF supplies high-quality reagents, enzymes, and components for research, biotech, and pharma, supporting the delivery of industrial and life sciences applications.
EKF develops devices, tests, and media for high-throughput, accurate analysis in central labs, ensuring reliable results and precise diagnostics for healthcare professionals.
EKF Diagnostics is pleased to announce that a new product training video for UltraCrit™ is now available.
UltraCrit™ is a CLIA-waived hematocrit analyzer with high-accuracy measurement for blood donor screening.
UltraCrit™ uses a unique technology developed in the United States. It is the first and only hematocrit/hemoglobin device to incorporate ultrasound technology. Using the highly accurate ultrasound method means that blood banks can be confident in minimizing the number of false deferrals and false acceptances.
For specific media enquiries please contact marketing@ekfdiagnostics.com.
For all other product enquiries, sales enquiries, technical support enquiries or anything else regarding our Point-of-Care, Life Sciences, or Central Laboratory products and services please visit our contact page.